Edition:
United Kingdom

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

0.83USD
13 Dec 2017
Change (% chg)

$0.01 (+1.28%)
Prev Close
$0.82
Open
$0.82
Day's High
$0.83
Day's Low
$0.80
Volume
132,924
Avg. Vol
235,577
52-wk High
$3.48
52-wk Low
$0.78

Chart for

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $263.85
Shares Outstanding(Mil.): 163.88
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Curis announces pricing of public offering of common stock

* Curis Inc - pricing of an underwritten public offering of 20 million shares of its common stock​ Source text for Eikon: Further company coverage:

14 Sep 2017

BRIEF-Curis and Aurigene announce CA-170 program update following data presented at ESMO 2017

* Curis and Aurigene announce CA-170 program update following data presented at ESMO 2017

11 Sep 2017

BRIEF-Curis reports Q2 loss per share $0.10

* Q2 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

03 Aug 2017

Earnings vs. Estimates